FDA Adverse Event Injury Summary report: N

MECTACER HEAD BIOLOX OPTION Ø 36

MDR report key: 5915951 · Received August 30, 2016

Report

Report Number
3005180920-2016-00438
Event Type
Injury
Date Received
August 30, 2016
Date of Event
August 1, 2016
Report Date
August 30, 2016
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
PMA / PMN Number
K131518
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS IS THE THIRD REVISION SURGERY UNDERWENT BY THE PATIENT. THE PRIMARY SURGERY TOOK PLACE ON (B)(6) 2013. THE PATIENT UNDERWENT THE FIRST REVISION SURGERY ON (B)(6) 2016 DUE TO PSOAS PAIN. CUP, LINER AND HEAD WERE REPLACED. THE SECOND REVISION SURGERY TOOK PLACE ON (B)(6) 2016 DUE TO ANTERIOR DISLOCATION. POSTERIOR APPROACH WAS USED FOR ALL REVISIONS ON THIS PATIENT. ADDITIONAL INFORMATION RECEIVED ON 04 AUGUST 2016 AND INCLUDES: THE CUP INVOLVED AND REPLACED DURING THE SECOND REVISION SURGERY WAS A NON-MEDACTA PRODUCT, THE HEAD WAS MEDACTA BRANDED. ALSO, THE CUP AND LINER REMOVED AND REPLACED IN THE THIRD REVISION WERE NON-MEDACTA IMPLANTS. BATCH REVIEWS PERFORMED ON 30 AUGUST 2016. LOT 131061: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 01 MARCH 2013. EXPIRATION DATE: 2018-01-31. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. MECTACER OPTION SLEEVE SIZE L, CODE 01.29.242A, LOT. 142135 (K131518) (B)(4) ITEMS MANUFACTURED AND RELEASED ON 10 JULY 2015. EXPIRATION DATE: 2020-05-31. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 3 ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT.

Description of Event or Problem · 1

REVISION DUE TO POSTERIOR DISLOCATION. LINER, HEAD AND SLEEVE REPLACED. NO X-RAYS OR EXPLANTS ARE AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
566389 MECTACER HEAD BIOLOX OPTION Ø 36 CERAMIC BALL HEAD LZO MEDACTA INTERNATIONAL SA 131061

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention